Two years ago South African company MJ MEDTECH a subsidiary of WUHAN GENERAL GROUP INC. announced plans to enter psychedelic sector after successful cannabis and CBD endeavors. Tests are now complete for Rat and cell line trials with the focus now being pushed towards analyzing the data and putting it into meaningful words that can show the true applications of psilocybin. They are testing for brain chemistry, inflammation, overall health and long term affects. The goal of these studies is to prove the efficacy of psilocybin as a treatment for mental health (ptsd, depression, anxiety, etc) as well as other physical ailments (high blood pressure, brain inflammation etc). Human trials are now being scheduled in accordance with Covid 19 limitations. They currently have several successful cannabis products and will follow suit with extracts and fruiting bodies when testing is complete.
Related Articles
Cordyceps Benefits: A Deep Dive Into the Scientific Research
Learn all about the science behind Cordyceps benefits for cognition, athletic performance and immunity in our latest blog.
How to Grow Lion’s Mane Mushrooms Indoors From Scratch in 9 Steps
Learn how to grow Lion’s Mane mushrooms in our complete step-by-step guide—from grain spawn to sterilization and everything in between.
Q&A: One Veteran’s Journey To Healing With Mushrooms
Learn how one veteran learned to heal his mind, body and spirit with microdosing and other plant medicine in our exclusive interview.